News

Approved financial statements for 2006

Prospectus approved

Registration of share capital increase

Trade exclusive subscription rights

Mottatt firmaattest

Share issue

Completion of acquisition and share issues

Notification of trade

Share issue

Allotted share options

NORD – general meeting held

Notice og extraordinary general meeting

Mandatory Notification of Trade

NorDiag acquires Genpoint

Fourth quarter results 2006

GenefecTM-case accepted for publishing

Outstanding results in Scottish research study

Presentation of the fourth quarter 2006

NorDiag exercises option for DNA analysis method

NorDiag signs license agreement with The Wellcome Trust

Pages